Cancer Evolution–Development: Experience of Hepatitis B Virus–Induced Hepatocarcinogenesis
Authors:
Open Access
- 1 February 2016
- journal article
- review article
- Published by MDPI AG in Current Oncology
- Vol. 23 (1) , 49-56
Abstract
Here, we present the basic concept and theoretical framework of a scientific hypothesis called Cancer Evolution– Development (“Cancer Evo-Dev”), based on our recent studies of the molecular mechanisms by which chronic infection with the hepatitis B virus induces hepatocarcinogenesis, together with related advances in that field. Several aspects central to our hypothesis are presented: Immune imbalance—caused by the interaction of genetic predispositions and environmental exposures such as viral infection—is responsible for the maintenance of chronic non-resolving inflammation. Non-resolving inflammation promotes the occurrence and progression of cancers, characterized by an evolutionary process of “mutation–selection–adaptation” for both viruses and host cells. Under a microenvironment of non-resolving inflammation, proinflammatory factors promote mutations in viral or host genomes by transactivation of the expression of cytidine deaminases and their analogues. Most cells with genomic mutations and mutated viruses are eliminated in the competition for survival in the inflammatory microenvironment. Only a small percentage of the mutated cells that alter their survival signal pathways and exhibit the characteristics of “stem-ness” can survive and function as cancer-initiating cells. Cancers generally develop with properties of “backward evolution” and “retro-differentiation,” indicating the indispensability of stem-like signal pathways in the evolution and development of cancers. The hypothesis of Cancer Evo–Dev not only lays the theoretical foundation for understanding the mechanisms by which inflammation promotes the development of cancers, but also plays an important role in specific prophylaxis, prediction, early diagnosis, and targeted treatment of cancers.Keywords
This publication has 55 references indexed in Scilit:
- HLA-DPPolymorphisms Affect the Outcomes of Chronic Hepatitis B Virus Infections, Possibly through Interacting with Viral MutationsJournal of Virology, 2013
- Effect of Antiviral Treatment With Nucleotide/Nucleoside Analogs on Postoperative Prognosis of Hepatitis B Virus–Related Hepatocellular Carcinoma: A Two-Stage Longitudinal Clinical StudyJournal of Clinical Oncology, 2013
- Hepatitis B Virus Core Promoter Mutations Contribute to Hepatocarcinogenesis by Deregulating SKP2 and Its Target, p21Gastroenterology, 2011
- Carboxyl-Terminal Truncated HBx Regulates a Distinct MicroRNA Transcription Program in Hepatocellular Carcinoma DevelopmentPLOS ONE, 2011
- Massive APOBEC3 Editing of Hepatitis B Viral DNA in CirrhosisPLOS Pathogens, 2010
- 99th Dahlem Conference on Infection, Inflammation and Chronic Inflammatory Disorders: Symbionts and immunopathology in chronic diseases: insights from evolutionClinical and Experimental Immunology, 2010
- Organ‐specific profiles of genetic changes in cancers caused by activation‐induced cytidine deaminase expressionInternational Journal of Cancer, 2008
- Analysis of hepatitis B viral load decline under potent therapy: Complex decay profiles observedHepatology, 2001
- Long-term mutation rates in the hepatitis B virus genomeMicrobiology, 2000
- Viral RNA-dependent DNA Polymerase: RNA-dependent DNA Polymerase in Virions of RNA Tumour VirusesNature, 1970